From: PPARγ Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes
PPARγ Pro12Ala | Ncase/Nnon-cases | HRa (95% CI) | p | HRb (95% CI) | p | HRc (95% CI) | p |
---|---|---|---|---|---|---|---|
Men | |||||||
Pro/Pro | 589/664 | 1.0 | 1.0 | ||||
Pro/Ala | 176/204 | 0.92 (0.73–1.17) | 0.51 | 0.92 (0.72–1.18) | 0.50 | Not relevant | |
Ala/Ala | 21/12 | 1.99 (0.98–4.05) | 0.06 | 2.12 (1.00–4.48) | 0.05 | Not relevant | |
Pro/Ala & Ala/Ala | 197/216 | 0.98 (0.78–1.23) | 0.86 | 0.98 (0.77–1.24) | 0.86 | Not relevant | |
Women | |||||||
Pro/Pro | 181/581 | 1.0 | 1.0 | 1.0 | |||
Pro/Ala | 62/193 | 0.96 (0.67–1.36) | 0.80 | 0.93 (0.65–1.35) | 0.75 | 0.96 (0.67–1.40) | 0.85 |
Ala/Ala | 2/15 | 0.38 (0.08–1.72) | 0.21 | 0.37 (0.08–1.72) | 0.21 | 0.40 (0.08–1.85) | 0.24 |
Pro/Ala & Ala/Ala | 64/208 | 0.91 (0.65–1.29) | 0.60 | 0.89 (0.62–1.27) | 0.53 | 0.92 (0.64–1.33) | 0.60 |